National HealthCare Corporation

As of June 30, 2026, National HealthCare Corporation carries a market capitalization of 2.93B, placing it among publicly traded companies globally. Its enterprise value stands at 2.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, National HealthCare Corporation has 15.66M shares outstanding.

As of June 30, 2026, National HealthCare Corporation trades at a trailing price-to-earnings ratio of 23.66. The price-to-sales ratio is 2.13, and the price-to-book ratio stands at 2.98.

As of June 30, 2026, National HealthCare Corporation trades at an EV/EBITDA multiple of 16.66 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.04 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 21.93 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. National HealthCare Corporation trades at an EV/FCF ratio of 21.37, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 2.78B versus a market cap of 2.93B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, National HealthCare Corporation maintains a current ratio of 1.86, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.78, indicating elevated leverage, while an interest coverage ratio of 74.55 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, National HealthCare Corporation posted a return on equity (ROE) of 13.08, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.46 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.05, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.85, useful for judging operating efficiency across full business cycles. The company generates approximately 89,782.89 in revenue per employee across its workforce of 15,199.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 114.85 indicates how many times National HealthCare Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, National HealthCare Corporation recorded 37.22M in income tax expense. That works out to an effective tax rate of 22.94, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 162.25M, leaving 122.77M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, National HealthCare Corporation's stock has gained approximately 105.71% over the past 52 weeks. The 50-day moving average sits at 198.96, while the 200-day moving average is 166.31.

Over the twelve months ended June 30, 2026, National HealthCare Corporation generated 1.36B in revenue and converted that into 122.77M in net income, yielding earnings per share of 7.93. EBITDA reached 166.65M, while operating income came in at 126.64M.

As of June 30, 2026, National HealthCare Corporation holds 183.98M in cash and equivalents against 27.49M in total debt, resulting in a net debt position of -34.32M. Total book value stands at 982.35M, with working capital of 178.11M providing operational flexibility.

National HealthCare Corporation produced 165.26M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -37.00M in capital expenditures, free cash flow totaled 128.26M - equivalent to 8.26 per share.

Over the twelve months ended June 30, 2026, National HealthCare Corporation posted a gross margin of 39.49, reflecting its pricing power and cost economics. The operating margin of 9.28 and net profit margin of 9.00 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, National HealthCare Corporation paid dividends of 2.24 per share. The dividend payout ratio of 27.35 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.35, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.61, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to National HealthCare Corporation shareholders.

National HealthCare Corporation's most recent stock split took place on June 24, 1985 with a 1:2 split ratio.

As of June 30, 2026, National HealthCare Corporation has an Altman Z-Score of 7.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.